Lisanti Capital Growth’s KalVista Pharmaceuticals KALV Stock Holding History

Lisanti Capital Growth’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-43,775	Closed	-$881K	–	130
2026 Q1	$881K	Buy	+43,775	New	+$706K	0.22%	97

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Lisanti Capital Growth's KALV Position: Q2 2026 in Review

Lisanti Capital Growth sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 43,775 shares — an estimated $881K sold.

Lisanti Capital Growth first reported a position in KALV in Q1 2026 and held it in 1 quarter. The position peaked at $881K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Lisanti Capital Growth reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Lisanti Capital Growth sold 43,775 KalVista Pharmaceuticals shares in Q2 2026, an estimated $881K.
Lisanti Capital Growth first reported a position in KalVista Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Lisanti Capital Growth's KalVista Pharmaceuticals position peaked at $881K in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Lisanti Capital Growth's 13F filing for Q2 2026, filed 10 Aug 2026.